Delivery Order SPE2DE24D0013-SPE2D625F3PPQ
- Not listed
- This delivery order, valued at $40,800, was awarded to Cepheid Inc. on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the provision of molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 2, 2025. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular...
- The Defense Department's Medical Supply Chain awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic testing supplies and services related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract, designated as delivery order 4569460623, is scheduled for completion by September 19, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents routine...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3PPQDelivery Order
The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, leveraging its GeneXpert platform and associated molecular reagents to support federal healthcare requirements. This delivery order aligns with Cepheid's existing federal contract portfolio, which includes significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs valued at over $35 million combined. The company has demonstrated consistent capability in delivering molecular diagnostic testing solutions across multiple federal agencies, including the VA, Indian Health Service, and Defense Health Agency, primarily for respiratory pathogen detection and infectious disease screening. The current award reflects the company's competitive positioning in the federal diagnostics market and supports critical testing capabilities for the Defense Department's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 9/16/25 |